Today there are more options than ever for managing migraine effectively. Find out what might work for you with this comprehensive guide to acute and preventive prescription drugs.
Ipsen presents 3 late-breaking presentations and 8 abstracts across rare cholestatic liver disease portfolio at AASLD 2024Iqirvo approved for use in the U.S. in June 2024, in the E.U. in September ...